Sampre Nutritions returns to profitability in FY26
Sampre Nutritions Limited reported a return to profitability for the financial year ended 31 March 2026, with a standalone net profit of ₹386.55 lakh against a net loss of ₹730.92 lakh in the previous year. Total revenue for FY26 rose to ₹4,405.76 lakh from ₹2,549.87 lakh in FY25. For Q4FY26, the company recorded a net profit of ₹182.23 lakh. The Board approved the audited results on 29 May 2026, receiving an unmodified opinion from statutory auditors N G Rao & Associates.

*this image is generated using AI for illustrative purposes only.
Sampre Nutritions Limited returned to profitability in the financial year ended 31 March 2026, reporting a net profit of ₹386.55 lakh compared to a net loss of ₹730.92 lakh in the previous year. The turnaround was driven by a significant increase in total revenue, which rose to ₹4,405.76 lakh from ₹2,549.87 lakh in FY25. For the quarter ended 31 March 2026 (Q4FY26), the company posted a net profit of ₹182.23 lakh, reversing the net loss of ₹714.29 lakh recorded in the corresponding quarter of the previous year.
The Board of Directors approved the standalone and consolidated audited financial results for the quarter and year ended 31 March 2026 at a meeting held on 29 May 2026. The statutory auditors, N G Rao & Associates, issued an audit report with an unmodified opinion on the financial results. The meeting was conducted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Performance
The company's operational efficiency improved as total expenses for FY26 increased to ₹4,149.23 lakh from ₹3,266.05 lakh in the prior year, a rise that was outpaced by the revenue growth. Profit before tax for the full year stood at ₹256.53 lakh, a turnaround from the loss before tax of ₹716.18 lakh in FY25. For Q4FY26, profit before tax was ₹52.21 lakh compared to a loss before tax of ₹699.55 lakh in the same period last year.
| Particulars | Q4FY26 (₹ in Lakhs) | Q4FY25 (₹ in Lakhs) | FY26 (₹ in Lakhs) | FY25 (₹ in Lakhs) |
|---|---|---|---|---|
| Total Revenue | 1,577.77 | 807.07 | 4,405.76 | 2,549.87 |
| Total Expenses | 1,525.56 | 1,506.62 | 4,149.23 | 3,266.05 |
| Profit Before Tax | 52.21 | (699.55) | 256.53 | (716.18) |
| Net Profit | 182.23 | (714.29) | 386.55 | (730.92) |
| Basic EPS | 0.87 | (3.40) | 1.84 | (3.48) |
Consolidated Results
On a consolidated basis, the company reported a net profit of ₹307.67 lakh for FY26, compared to a net loss of ₹767.23 lakh in the previous year. Total consolidated revenue for the year increased to ₹4,377.92 lakh from ₹2,549.87 lakh in FY25. For the quarter ended 31 March 2026, the consolidated net profit was ₹134.59 lakh. The financial results include the performance of subsidiaries Sampre Nutritions Holding Limited and Sampre Nutritions-FZCO.
Historical Stock Returns for Sampre Nutritions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.73% | -17.93% | -35.61% | -58.09% | +76.48% | +137.20% |
What specific strategic initiatives drove the 72% revenue surge, and are these growth rates sustainable for FY27?
How will the company utilize its restored profitability to fund future expansion or reduce existing debt?
What are the growth projections for the subsidiaries, Sampre Nutritions Holding Limited and Sampre Nutritions-FZCO, in the coming year?






























